FDA Accepts New Drug Application for INSYS Therapeutics' Naloxo...

07/03/19

FDA Accepts New Drug Application for INSYS Therapeutics' Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose  EIN News

INSYS Therapeutics, Inc. (OTCMKTS: INSYQ), announced today that its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its.

[more]